ELIZABETH MILLS: Open Payments
NPI 1134520133 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 41 payments from 14 companies in 2025. Trend: 2023 $860 · 2024 $1,139 · 2025 $1,345
Food & beverage: $1,310Education: $35
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $593 |
| Sumitomo Pharma America, Inc. | 14 | $314 |
| ABBVIE INC. | 3 | $78 |
| UROGEN PHARMA, INC. | 2 | $69 |
| Procept Biorobotics Corporation | 1 | $50 |
| ACCORD HEALTHCARE, INC. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Antares Pharma, Inc. | 2 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
Products named: INTERSTIM, GEMTESA, ALTAVIVA, BOTOX, AQUABEAM ROBOTIC SYSTEM, ORGOVYX, Camcevi, ERLEADA.
Industry payments across IN — which companies pay providers there.
